From Medscape Special Reports

Special Report: FDA Advisory Panel Supports Morcellation Restrictions

July 25, 2014


FDA Advisory Panel Voices Concern About Morcellation Risk
In light of the newly recognized cancer risk, the FDA's obstetrics device panel suggested further restrictions on the use of laparoscopic power morcellators for uterine fibroid surgery.

FDA Panel Grapples With 'Weak' Data on Morcellation Risk
An FDA advisory panel yesterday heard 2 vastly different estimates for the risk for an unsuspected malignancy in women undergoing uterine fibroid surgery.

Uterine Cancer Rare in Hysterectomy With Morcellation, Study Shows
A large, nationwide study has estimated that 27 of 10,000 women had uterine cancer at the time of minimally invasive hysterectomy with morcellation, and that prevalence increases with age.

The Morcellation Controversy: A Timeline
Read a summary of major events leading up to the FDA warning against morcellation in hysterectomy and myomectomy.


Morcellation Controversy Could Have Been Avoided With Surveillance, Former IOM Chair Says
Dr. David Challoner says big data monitoring techniques could have alerted the FDA much earlier to problems associated with power morcellators.

Harvard Surgeon Aims to Ban Morcellation
Dr. Noorchashm talks to Medscape about the morcellation alternatives that he feels gynecologic surgeons need to consider.

AAGL Board Member Defends Morcellation
AAGL Board Member Jubilee Brown, MD, reacts to the recent FDA statement that power morcellation shouldn't be used for hysterectomy or myomectomy in most women with uterine fibroids.

Morcellation Has Role in Patient Care, Societies Say
The American College of Obstetricians and Gynecologists and the European Society for Gynecologic Endoscopy have issued statements defending the role of power morcellation in patient care.

Medscape©  WebMD, LLC

Editor's Note

Get the latest data concerning risks associated with morcellators, and find out why some members of an FDA advisory panel say the devices should carry a black box warning.
- Stephanie Cajigal, Editor, Medscape OB/GYN & Women's Health